A critical advance in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This vital cancer inhibitor protein is frequently inactivated in many forms of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research